About Anika
Anika is a publicly listed company based in Cayman Islands founded in 1983. Anika Therapeutics - Joint Preservation To Restore Active Living. The company has 288 employees. Its website anika.com draws about 22 thousand monthly visits. Anika offers products and services including Integrity Implant System, Hyalofast, Tactoset, Cingal, and Monovisc. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Anika Therapeutics, Inc.
Company details
Anika Therapeutics was founded in 1983 and is headquartered in the Cayman Islands. The company operates globally within the orthopedic sector, with a focus on joint preservation through early intervention strategies. Treatment options for orthopedic conditions are provided, emphasizing advancements that support joint health and mobility. Operations include research and development of therapies aimed at restoring active lifestyles, serving healthcare providers and patients worldwide.
- Annual Revenue$112.82 M (USD)-5.91as on Dec 31, 2025
- Net Profit-$10.88 M (USD)80.7as on Dec 31, 2025
- EBITDA-$5.32 M (USD)-1006.64as on Dec 31, 2025
- Employee Count288
Products & Services of Anika
Anika offers a comprehensive portfolio of products and services, including Integrity Implant System, Hyalofast, Tactoset, Cingal, and Monovisc.
Porous scaffold for tissue regeneration in joint repairs
Hyaluronic acid technology supporting tissue healing
Injectable for treating insufficiency fractures and hardware augmentation
Hyaluronic acid for osteoarthritis pain relief
Viscosupplementation for joint lubrication
Apps and channels of Anika
its YouTube channel Anika has 1.97K subscribers and 30 videos.
Videos from Anika
The most watched videos on Anika's YouTube channel, Anika (1.97K subscribers). Click a video to play it here.
More on Anika.
People of Anika
91 people are tracked at Anika (29 in leadership, 6 in board & advisors, 56 in team); the tracked headcount is 288.
| Name | Role | Group |
|---|---|---|
Mira Leiwant | VP, Regulatory Affairs, Quality, & Clinical Affairs | Leadership |
Kevin Stone | VP & General Manager, Sports Medicine | Leadership |
Aislyn Arnone | Marketing Director | Leadership |
Jason Walters | Distributor | General Manager | Leadership |
Anne Nunes | VP, Operations | Leadership |
Cheryl R. Blanchard | President & CEO | Leadership |
Ben Joseph | VP, Commercial & Corporate Development | Leadership |
Steven Ek | VP, Research & Development | Leadership |
Brian Horne | Vice President, Information Technology | Leadership |
George Lakomy | Executive Director Of Operations | Leadership |
Jennifer T. | Director, HR Operations & Shared Services | Leadership |
Mustafa Saai | Director Of International Joint Preservation & Restoration - Sales | Leadership |
Jim Leatham | Business Development Director, Western Europe And Canada | Leadership |
Gianluca Ruffi | Director Of International Regenerative Sales | Leadership |
Sandy Havercroft | Marketing Director - International | Leadership |
Marley Jones | Vice President Finance | Leadership |
Matthew M. Mannarino | Director Of Research & Development | Leadership |
Matt Hall | Director, Corporate Development And Investor Relations | Leadership |
David B. Colleran | Executive Vice President, General Counsel And Corporate Secretary | Leadership |
Weimin Yue Ph.D., Rac | Director Quality Assurance | Leadership |
71 more people are available in the full profile.
Complete people profiles for Anika
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Anika
Anika is a publicly listed company on the NASDAQ with ticker symbol ANIK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Dec 2003
- Listed onFRA: AKP
- Listed entityAnika Therapeutics Inc.
- Exchange sectorHealth technology
- ISINUS0352551081
- Share price$20.53 (+0.29% on the day) · 2026-10-13
- Market capitalisation$274.8M
- EPS (diluted, trailing year)$-0.27
- Volume (last session)96,190
Financials of Anika
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $112.8M | -$10.9M | -$5.3M |
| 2024 | $119.9M | -$56.4M | $587,000 |
| 2023 | $120.8M | -$82.7M | $6.3M |
| 2022 | $156.2M | -$14.9M | -$3.0M |
| 2021 | $147.8M | $4.1M | -$1.9M |
Detailed financial statements for Anika
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Anika
The website of Anika (anika.com) receives about 22.2K visits a month.
- Monthly visits22.2K
▼ 3.2% vs previous month
Websites whose visitors overlap most with Anika. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
birminghammedicalnews.com | birminghammedicalnews.com | 100% | #4,783,555 | – | |
bioproimplants.com | bioproimplants.com | 100% | #3,329,085 | – | |
drorthooil.com | drorthooil.com | 83% | #155,849 | – | |
| arthrex.com | 78% | 490.7K | #95,556 | View details | |
londonfootankle.co.uk | londonfootankle.co.uk | 71% | #2,740,416 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Anika
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Anika
Complete news archive for Anika
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anika
Anika was founded in 1983.
Anika is headquartered in Cayman Islands.
Anika has 288 employees.
Annual revenue of Anika is $112.82M as on Dec 31, 2025.
Anika Therapeutics was founded in 1983 and is headquartered in the Cayman Islands. The company operates globally within the orthopedic sector, with a focus on joint preservation through early intervention strategies. Treatment options for orthopedic conditions are provided, emphasizing advancements that support joint health and mobility. Operations include research and development of therapies aimed at restoring active lifestyles, serving healthcare providers and patients worldwide.
Anika offers Integrity Implant System, Hyalofast, Tactoset, Cingal, and Monovisc.
Yes, Anika is publicly traded on NASDAQ under the ticker symbol ANIK.
Anika operates through Anika Therapeutics, Inc..